Bridging the Global Divide: ERS Launches ‘Pulmonology Across Borders’ to Address International Health Disparities

12 November, 2026 — The European Respiratory Society (ERS) has officially inaugurated a transformative digital initiative, Pulmonology Across Borders, a podcast series designed to deconstruct the systemic, geographical, and clinical barriers facing respiratory patients worldwide. By leveraging the reach of the ERS Respiratory Channel, the society aims to move beyond traditional academic discourse, pivoting instead toward a nuanced examination of lived experience, regional policy, and the stark disparities in healthcare infrastructure.

Main Facts: A New Era for Respiratory Advocacy

The launch of Pulmonology Across Borders marks a strategic shift for the ERS. Rather than focusing exclusively on clinical trial outcomes or laboratory breakthroughs, the podcast format centers on the "reality on the ground." Each instalment is structured as a three-part mini-series, curated by ERS officers and featuring a panel of international experts.

The core mission is threefold:

  1. Cultural and Geographical Context: Exploring how respiratory disease manifests differently across diverse socio-economic landscapes.
  2. Policy and Practice: Analyzing the legislative and administrative hurdles that prevent equitable access to care.
  3. The Patient Experience: Bringing the patient perspective to the forefront of medical education, ensuring that clinicians understand the human narrative behind the diagnostic code.

Chronology: The Evolution of ERS Digital Content

The introduction of this podcast series is the culmination of a multi-year digital transformation strategy within the ERS.

  • 2023–2024: The ERS Respiratory Channel expanded its library to include webinars and quick-fire clinical updates. However, internal surveys and member feedback indicated a growing demand for long-form, narrative-driven content that addressed the "why" behind health inequalities.
  • Early 2026: The ERS leadership approved the concept of a multi-part, globally-focused audio series. The objective was to create a platform that could accommodate the complexity of global health policy, which often cannot be captured in a 15-minute conference presentation.
  • November 2026: The pilot series, focusing on Interstitial Lung Disease (ILD), was released to the public, setting the blueprint for future assemblies to curate their own thematic deep-dives.

Supporting Data: The Case for Interstitial Lung Disease (ILD)

The debut series focuses on the global burden of ILD—a group of disorders characterized by progressive scarring of the lung tissue. The choice of ILD as the inaugural topic is deliberate; it is a condition where diagnostic delay and lack of access to anti-fibrotic therapies are most pronounced in low-to-middle-income countries (LMICs).

Dr. Nazia Chaudhuri, Secretary of ERS Group 12.01 (Idiopathic Interstitial Pneumonias), serves as the host for this series. She is joined by Dr. Asmita Mehta (India) and Dr. Alexandre Franco Amaral (Brazil), two regions where the clinical presentation of ILD is often complicated by environmental factors and limited access to high-resolution computed tomography (HRCT) scanning.

The Three Pillars of the ILD Series:

  • Part 1: Epidemiology and Early Diagnosis: The series opens with a frank discussion on the diagnostic odyssey. In many regions, the lack of multidisciplinary teams (MDTs) leads to misdiagnosis, where ILD is often mistaken for tuberculosis—a common diagnostic pitfall in parts of the Global South.
  • Part 2: The Geography of Care: The second installment tackles the infrastructure gap. Even when a diagnosis is reached, the availability of specialized interstitial lung disease clinics remains heavily skewed toward urban, academic medical centers, leaving rural populations significantly underserved.
  • Part 3: Access to Targeted Therapies: The concluding segment addresses the "access paradox." While novel anti-fibrotic medications exist, their cost and the regulatory hurdles for clinical trial participation remain formidable barriers. The experts discuss how global partnerships might eventually harmonize access to these life-extending treatments.

Official Responses and Strategic Vision

The ERS leadership views this podcast not as a peripheral project, but as a central component of its advocacy mission. By inviting all ERS assemblies to propose their own series, the society is effectively crowdsourcing the most pressing issues in respiratory medicine.

"We are moving from a model of top-down education to a horizontal exchange of knowledge," notes an ERS spokesperson. "When we hear from a clinician in India or Brazil, it changes the way our members in Europe perceive their own practices. It highlights the universality of the struggle, while respecting the uniqueness of the local context."

The ERS is actively encouraging proposals from all its assemblies. The criteria for these future series are rigorous: they must highlight lived experiences, dissect respiratory policies, and emphasize the necessity of multidisciplinary collaboration. This open-call strategy is intended to ensure that the podcast remains a democratic platform, representing the diverse interests of the global respiratory community.

Implications: The Future of Global Health Discourse

The implications of Pulmonology Across Borders extend far beyond the auditory format. By digitizing the nuances of regional healthcare, the ERS is creating a living archive of global respiratory health.

1. Shaping Future Policy

The podcast provides a repository of case studies that can be utilized by policymakers. When health ministers or hospital administrators examine the systemic gaps identified in the podcast—such as the lack of trained radiologists for ILD identification or the bureaucratic barriers to drug importation—they are presented with expert-led evidence that highlights the human cost of these inefficiencies.

2. Standardizing the "Multidisciplinary" Approach

The emphasis on multidisciplinary collaboration in every episode serves as a model for how future respiratory departments should be structured. The podcast showcases the vital roles played by not just pulmonologists, but also nurses, physiotherapists, radiologists, and patient advocates. By broadcasting these conversations, the ERS is fostering a global standard of care that prioritizes the patient-centered MDT approach.

3. Strengthening the ERS Community

As the digital divide continues to shrink, the ERS is positioning itself as the primary connector for respiratory professionals worldwide. This podcast acts as a bridge, allowing clinicians in isolated areas to feel part of a broader, supportive, and international scientific community. It creates a sense of shared responsibility, where the burden of one region is acknowledged as a challenge for the entire global respiratory field.

Conclusion: A Call to Action

The launch of Pulmonology Across Borders is a bold step toward a more equitable future in medicine. It challenges the medical community to listen as much as it researches and to advocate as much as it treats.

For those looking to engage with the series, the first three episodes are currently live on the ERS Respiratory Channel. The series is essential listening for any healthcare professional, policy researcher, or student interested in the complexities of global health.

As the ERS looks toward the next year, the success of this initiative will be measured not just by the number of downloads, but by its capacity to spark tangible change in diagnostic pathways and policy frameworks. The invitation remains open: if you have a story to tell or a regional crisis to highlight, the ERS is listening. The borders between respiratory health systems are beginning to dissolve, replaced by a channel of communication that promises to reshape the way we view the global burden of disease.


To listen to the first three episodes of the ILD series, visit the ERS Respiratory Channel. For those interested in submitting a proposal for a future mini-series, please reach out to the ERS secretariat via their official contact portal.

More From Author

Wandercraft’s Revolutionary Eve Exoskeleton Launches Commercially in U.S., Offering Hands-Free Mobility for Spinal Cord Injury Patients